XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 60 filers reported holding XENON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,593,012 | +44.6% | 427,125 | +63.0% | 0.01% | +66.7% |
| Q2 2023 | $10,090,975 | +332.0% | 262,107 | +301.6% | 0.00% | +200.0% |
| Q1 2023 | $2,335,870 | +18725.5% | 65,266 | -79.3% | 0.00% | -75.0% |
| Q4 2022 | $12,408 | -99.9% | 314,673 | -8.0% | 0.00% | -20.0% |
| Q3 2022 | $12,348,000 | +132.0% | 342,031 | +95.5% | 0.01% | +150.0% |
| Q2 2022 | $5,322,000 | -40.7% | 174,962 | -40.4% | 0.00% | -33.3% |
| Q1 2022 | $8,979,000 | -1.5% | 293,729 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $9,120,000 | +294.8% | 291,946 | +93.1% | 0.00% | +200.0% |
| Q3 2021 | $2,310,000 | +728.0% | 151,197 | +907.3% | 0.00% | – |
| Q2 2021 | $279,000 | +153.6% | 15,010 | +35.0% | 0.00% | – |
| Q2 2019 | $110,000 | -2.7% | 11,120 | 0.0% | 0.00% | – |
| Q1 2019 | $113,000 | +61.4% | 11,120 | 0.0% | 0.00% | – |
| Q4 2018 | $70,000 | -52.4% | 11,120 | 0.0% | 0.00% | – |
| Q3 2018 | $147,000 | +44.1% | 11,120 | 0.0% | 0.00% | – |
| Q2 2018 | $102,000 | +88.9% | 11,120 | 0.0% | 0.00% | – |
| Q1 2018 | $54,000 | +74.2% | 11,120 | 0.0% | 0.00% | – |
| Q4 2017 | $31,000 | – | 11,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |